IO Biotech (IOBT) Short Interest Ratio & Short Volume → Must-See: Elon’s New Invention is Absolutely Insane (From InvestorPlace) (Ad) Free IOBT Stock Alerts $1.38 -0.02 (-1.43%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media IO Biotech Short Interest DataCurrent Short Volume39,500 sharesPrevious Short Volume61,800 sharesChange Vs. Previous Month-36.08%Dollar Volume Sold Short$57,670.00Short Interest Ratio / Days to Cover0.3Last Record DateApril 30, 2024Outstanding Shares65,880,000 sharesFloat Size41,350,000 sharesShort Percent of Float0.10%Today's Trading Volume53,100 sharesAverage Trading Volume104,122 sharesToday's Volume Vs. Average51% Short Selling IO Biotech ? Sign up to receive the latest short interest report for IO Biotech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatIOBT Short Interest Over TimeIOBT Days to Cover Over TimeIOBT Percentage of Float Shorted Over Time Ad InvestorPlaceMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… IO Biotech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202439,500 shares $57,670.00 -36.1%0.1%0.3 $1.46 4/15/202461,800 shares $93,936.00 -9.4%0.2%0.5 $1.52 3/31/202468,200 shares $117,986.00 -16.4%0.2%0.5 $1.73 3/15/202481,600 shares $134,640.00 +50.3%0.2%0.6 $1.65 2/29/202454,300 shares $86,880.00 +10.4%0.1%0.4 $1.60 2/15/202449,200 shares $74,784.00 +2.5%0.1%0.3 $1.52 Get the Latest News and Ratings for IOBT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for IO Biotech and its competitors with MarketBeat's FREE daily newsletter. 1/31/202448,000 shares $83,520.00 -30.9%0.1%0.5 $1.74 1/15/202469,500 shares $131,355.00 -14.1%0.2%0.7 $1.89 12/31/202380,900 shares $152,092.00 -56.4%0.2%0.6 $1.88 12/15/2023185,500 shares $262,482.50 -7.7%0.5%1.5 $1.42 11/30/2023200,900 shares $235,053.00 +17.0%0.6%1.3 $1.17 11/15/2023171,700 shares $168,266.00 +3.5%0.5%1.2 $0.98 10/31/2023165,900 shares $142,159.71 +26.9%0.9%1 $0.86 10/15/2023130,700 shares $150,305.00 +12.4%0.7%0.8 $1.15 9/30/2023116,300 shares $163,983.00 -57.2%0.7%0.9 $1.41 9/15/2023271,800 shares $385,956.00 -57.0%1.5%2.1 $1.42 8/31/2023631,700 shares $1.16 million +15.5%3.6%3 $1.84 8/15/2023546,900 shares $1.09 million +29.9%3.1%2.7 $2.00 7/31/2023421,000 shares $774,640.00 -5.9%2.1%2.4 $1.84 7/15/2023447,500 shares $796,550.00 +5.7%2.3%2.8 $1.78 6/30/2023423,200 shares $829,472.00 -11.2%2.2%2.7 $1.96 6/15/2023476,300 shares $976,415.00 +11.9%2.4%3.2 $2.05 5/31/2023425,700 shares $885,456.00 +36.3%2.2%13.2 $2.08 5/15/2023312,400 shares $624,800.00 No Change1.7%11.2 $2.00 10/31/20229,400 shares $23,218.00 +59.3%0.1%0.2 $2.47 10/15/20225,900 shares $14,042.00 -14.5%0.0%0.1 $2.38 9/30/20226,900 shares $18,699.00 -25.0%0.0%0.2 $2.71 9/15/20229,200 shares $26,680.00 +13.6%0.1%0.2 $2.90 8/31/20228,100 shares $26,892.00 +1,250.0%0.0%0.2 $3.32 8/15/2022600 shares $2,406.00 -50.0%N/A0 $4.01 7/31/20221,200 shares $4,644.00 -62.5%0.0%0 $3.87 7/15/20223,200 shares $13,440.00 -74.2%0.0%0.1 $4.20 6/30/202212,400 shares $57,908.00 +106.7%0.1%0.2 $4.67 6/15/20226,000 shares $23,640.00 +106.9%0.0%0.1 $3.94 5/31/20222,900 shares $14,007.00 -44.2%0.0%0.1 $4.83 5/15/20225,200 shares $39,156.00 -50.0%0.0%0.1 $7.53 4/30/202210,400 shares $75,400.00 -24.6%0.1%0.3 $7.25 4/15/202213,800 shares $99,222.00 +68.3%0.1%0.5 $7.19 3/31/20228,200 shares $43,460.00 -78.3%N/A0 $5.30 3/15/202237,700 shares $143,260.00 +19.7%0.3%1.4 $3.80Must-See: Elon’s New Invention is Absolutely Insane (Ad)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… IOBT Short Interest - Frequently Asked Questions What is IO Biotech's current short interest? Short interest is the volume of IO Biotech shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 39,500 shares of IOBT short. 0.10% of IO Biotech's shares are currently sold short. Learn More on IO Biotech's current short interest. What is a good short interest percentage for IO Biotech? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.10% of IO Biotech's floating shares are currently sold short. Is IO Biotech's short interest increasing or decreasing? IO Biotech saw a decrease in short interest in April. As of April 30th, there was short interest totaling 39,500 shares, a decrease of 36.1% from the previous total of 61,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is IO Biotech's float size? IO Biotech currently has issued a total of 65,880,000 shares. Some of IO Biotech's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. IO Biotech currently has a public float of 41,350,000 shares. How does IO Biotech's short interest compare to its competitors? 0.10% of IO Biotech's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to IO Biotech: Anixa Biosciences, Inc. (2.08%), Clearside Biomedical, Inc. (0.45%), Eton Pharmaceuticals, Inc. (0.36%), Genelux Co. (11.62%), YS Biopharma Co., Ltd. (0.32%), ProPhase Labs, Inc. (1.88%), Annovis Bio, Inc. (14.41%), Milestone Pharmaceuticals Inc. (0.81%), Barinthus Biotherapeutics plc (0.05%), Assertio Holdings, Inc. (12.08%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short IO Biotech stock? Short selling IOBT is an investing strategy that aims to generate trading profit from IO Biotech as its price is falling. IOBT shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against IO Biotech? A short squeeze for IO Biotech occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of IOBT, which in turn drives the price of the stock up even further. How often is IO Biotech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IOBT, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: ANIX Short Interest CLSD Short Interest ETON Short Interest GNLX Short Interest YS Short Interest PRPH Short Interest ANVS Short Interest MIST Short Interest BRNS Short Interest ASRT Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:IOBT) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaNext President (Not Trump. Not Biden.)The Freeport SocietyUrgent Nvidia WarningAltimetryElon’s New Device is About to Shock the WorldInvestorPlace"The Biggest Drug Ever" Is ComingBehind the MarketsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders